Newsletter

397030 - April Bio Co., Ltd.

397030 Summary
Biopharma
Stock Price & Overview
₩17,800 +1,030 (+6.14%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩17,800  ≈ US$13  ·  Market cap ₩0.5tn (≈ $350m)
Why this page exists. Korean issuers file to DART, not the SEC, and almost nothing is published in English. Titles here are translated; where kstock has read the filing, the row carries the explanation and the amount in won and dollars. How we pick »

397030 DART Filings

DART

Material matter affecting investment judgment

Filing08/21/26title translated
DART

Change of largest shareholder

Filing08/19/26title translated
DART

Half-Year Report

Periodic08/13/26title translated
DART

Resolution to convene an extraordinary general meeting

Filing08/11/26title translated
DART

Record date set, shareholder register closed

Filing08/11/26title translated
DART

Share pledge that could change the largest shareholder

Filing07/24/26title translated
DART

Change of largest shareholder

Filing07/24/26title translated
DART

Securities issuance result (voluntary)

Filing07/23/26title translated
DART

Securities issuance result (voluntary)

Filing07/23/26title translated
DART

Securities issuance result (voluntary)

Filing07/23/26title translated
DART

Material event report (paid-in capital increase) ×2

Filing07/23/26title translated
DART

Agreement on a change of control

Filing07/23/26title translated
DART

Material matter affecting investment judgment

Filing07/21/26title translated
DART

KRX Demands an Answer to a Rumor or Media Report

Exchange inquiry06/25/26title translated
DART

Material event report (paid-in capital increase) ×3

Filing06/25/26title translated
DART

Agreement on a change of control

Filing06/25/26title translated
DART

KRX Demands an Answer to a Rumor or Media Report

Exchange inquiry06/24/26title translated
DART

Quarterly Report

Periodic05/15/26title translated
8 routine filings (insider holdings reports, IR schedules)DART

Insider / Major Shareholder Holdings Report

Ownership08/28/26title translated
DART

5% Ownership Report — Large Holdings

Ownership08/26/26title translated
DART

Insider / Major Shareholder Holdings Report ×3

Ownership08/19/26title translated
DART

Insider / Major Shareholder Holdings Report

Ownership07/29/26title translated
DART

Insider / Major Shareholder Holdings Report

Ownership07/24/26title translated
DART

5% Ownership Report — Large Holdings

Ownership07/24/26title translated
DART

5% Ownership Report — Large Holdings

Ownership07/01/26title translated
DART

5% Ownership Report — Short Form

Ownership06/10/26title translated
26 filings on file, grouped where one event produced many. Source: DART, operated by Korea's Financial Supervisory Service.

Similar to 397030

SymbolLast Price
085660Chabiotech Co., Ltd.₩8,090
+2.1%
476060Onconic Therapeutics, Inc.₩16,440
-3.9%
041960Komipharm International Co., Ltd.₩9,710
+3.5%
317450Myungin Pharm₩44,650
+0.0%
001060JW Pharmaceutical₩27,500
+1.3%
456160G2GBIO, Inc.₩37,950
+5.7%
019170Shinpoong Pharmaceutical Co., Ltd.₩10,010
-0.9%
358570GI Innovation, Inc.₩8,090
+6.2%
086900Medy-Tox, Inc.₩69,600
+0.4%
249420Ildong Pharm₩15,030
-0.5%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.